Expression profiling of apoptosis-related genes in megakaryocytes: BNIP3 is downregulated in primary myelofibrosis

Experimental Hematology

Volumn 36, Issue 12, 2008, Pages 1728-1738

  Theophile, Katharina ^a   Hussein, Kais ^a   Kreipe, Hans ^a   Bock, Oliver ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; JANUS KINASE 2; PROTEIN BNIP3; PROTEIN KINASE C BETA;

ADOLESCENT; ADULT; AGED; APOPTOSIS; ARTICLE; BONE MARROW CELL; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MEGAKARYOCYTE; MYELOID METAPLASIA; NICK END LABELING; PRIORITY JOURNAL; PROTEIN METHYLATION; REAL TIME POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL PROLIFERATION; DOWN-REGULATION; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; MEGAKARYOCYTES; MEMBRANE PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PRIMARY MYELOFIBROSIS; PROTEIN KINASE C; PROTO-ONCOGENE PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 55549099206     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2008.07.011     Document Type: Article

References (41)

1. Szalai G., LaRue A.C., and Watson D.K. Molecular mechanisms of megakaryopoiesis. Cell Mol Life Sci 63 (2006) 2460-2476
2. Nurden A.T. Qualitative disorders of platelets and megakaryocytes. J Thromb Haemost 3 (2005) 1773-1782
3. Pang L., Weiss M.J., and Poncz M. Megakaryocyte biology and related disorders. J Clin Invest 115 (2005) 3332-3338
4. Junt T., Schulze H., Chen Z., et al. Dynamic visualization of thrombopoiesis within bone marrow. Science 317 (2007) 1767-1770
5. De Botton S., Sabri S., Daugas E., et al. Platelet formation is the consequence of caspase activation within megakaryocytes. Blood 100 (2002) 1310-1317
6. Italiano J.E.J., and Shivdasani R.A. Megakaryocytes and beyond: the birth of platelets. J Thromb Haemost 1 (2003) 1174-1182
7. Battinelli E.M., Hartwig J.H., and Italiano J.E.J. Delivering new insight into the biology of megakaryopoiesis and thrombopoiesis. Curr Opin Hematol 14 (2007) 419-426
8. Kaluzhny Y., and Ravid K. Role of apoptotic processes in platelet biogenesis. Acta Haematol 111 (2004) 67-77
9. Gordge M.P. Megakaryocyte apoptosis: sorting out the signals. Br J Pharmacol 145 (2005) 271-273
10. Tefferi A., Thiele J., Orazi A., et al. Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel. Blood 110 (2007) 1092-1097
11. Tefferi A. Pathogenesis of myelofibrosis with myeloid metaplasia. J Clin Oncol 23 (2005) 8520-8530
12. Martyré M.C., Romquin N., Le Bousse-Kerdiles M.C., et al. Transforming growth factor-beta and megakaryocytes in the pathogenesis of idiopathic myelofibrosis. Br J Haematol 88 (1994) 9-16
13. Castro-Malaspina H., Rabellino E.M., Yen A., et al. Human megakaryocyte stimulation of proliferation of bone marrow fibroblasts. Blood 57 (1981) 781-787
14. Schmitt A., Jouault H., Guichard J., et al. Pathologic interaction between megakaryocytes and polymorphonuclear leukocytes in myelofibrosis. Blood 96 (2000) 1342-1347
15. Centurione L., Di Baldassarre A., Zingariello M., et al. Increased and pathologic emperipolesis of neutrophils within megakaryocytes associated with marrow fibrosis in GATA-1(low) mice. Blood 104 (2004) 3573-3580
16. James C., Ugo V., Le Couédic J., et al. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature 434 (2005) 1144-1148
17. Tefferi A., and Gilliland D.G. Oncogenes in myeloproliferative disorders. Cell Cycle 6 (2007) 550-566
18. Macdonald D., and Cross N.C. Chronic myeloproliferative disorders: the role of tyrosine kinases in pathogenesis, diagnosis and therapy. Pathobiology 74 (2007) 81-88
19. Delhommeau F., Pisani D.F., James C., et al. Oncogenic mechanisms in myeloproliferative disorders. Cell Mol Life Sci 63 (2006) 2939-2953
20. Bennett M., and Stroncek D.F. Recent advances in the bcr-abl negative chronic myeloproliferative diseases. J Transl Med 4 (2006) 41
21. Thiele J., and Kvasnicka H.M. Diagnostic differentiation of essential thrombocythemia from thrombocythemias associated with chronic idiopathic myelofibrosis by discriminate analysis of bone marrow features-a clinicopathological study on 272 patients. Histol Histopathol 18 (2003) 93-102
22. Ahmed A., and Chang C.J. Chronic idiopathic myelofibrosis: clinicopathologic features, pathogenesis, and prognosis. Arch Pathol Lab Med 130 (2006) 1133-1143
23. Schulze H., and Shivdasani R.A. Mechanisms of thrombopoiesis. J Thromb Haemost 3 (2005) 1717-1724
24. Lehmann U., and Kreipe H. Real-time PCR analysis of DNA and RNA extracted from formalin-fixed and paraffin-embedded biopsies. Methods 25 (2001) 409-418
25. Lewis F., Maughan N.J., Smith V., et al. Unlocking the archive-gene expression in paraffin-embedded tissue. J Pathol 195 (2001) 66-71
26. Antonov J., Goldstein D.R., Oberli A., et al. Reliable gene expression measurements from degraded RNA by quantitative real-time PCR depend on short amplicons and a proper normalization. Lab Invest 85 (2005) 1040-1050
27. Theophile K., Jonigk D., Kreipe H., et al. Amplification of mRNA from laser-microdissected single or clustered cells in formalin-fixed and paraffin-embedded tissues for application in quantitative real-time PCR. Diagn Mol Pathol 17 (2008) 101-106
28. Thiele J., Kvasnicka H.M., Facchetti F., et al. European consensus on grading bone marrow fibrosis and assessment of cellularity. Haematologica 90 (2005) 1128-1132
29. Buhr T., Büsche G., Choritz H., et al. Evolution of myelofibrosis in chronic idiopathic myelofibrosis as evidenced in sequential bone marrow biopsy specimens. Am J Clin Pathol 119 (2003) 152-158
30. Hussein K., Brakensiek K., Buesche G., et al. Different involvement of the megakaryocytic lineage by the JAK2 V617F mutation in Polycythemia vera, essential thrombocythemia and chronic idiopathic myelofibrosis. Ann Hematol 86 (2007) 245-253
31. Bock O., Schlué J., Mengel M., et al. Thrombopoietin receptor (Mpl) expression by megakaryocytes in myeloproliferative disorders. J Pathol 203 (2004) 609-615
32. Murai M., Toyota M., Satoh A., et al. Aberrant DNA methylation associated with silencing BNIP3 gene expression in haematopoietic tumours. Br J Cancer 92 (2005) 1165-1172
33. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25 (2001) 402-408
34. Radonić A., Thulke S., Mackay I.M., et al. Guideline to reference gene selection for quantitative real-time PCR. Biochem Biophys Res Commun 313 (2004) 856-862
35. Kvasnicka H.M., and Thiele J. Classification of Ph-negative chronic myeloproliferative disorders-morphology as the yardstick of classification. Pathobiology 74 (2007) 63-71
36. Schwer H.D., Lecine P., Tiwari S., et al. A lineage-restricted and divergent beta-tubulin isoform is essential for the biogenesis, structure and function of blood platelets. Curr Biol 11 (2001) 579-586
37. Sakhinia E., Glennie C., Hoyland J.A., et al. Clinical quantitation of diagnostic and predictive gene expression levels in follicular and diffuse large B-cell lymphoma by RT-PCR gene expression profiling. Blood 109 (2007) 3922-3928
38. Mellor H.R., and Harris A.L. The role of the hypoxia-inducible BH3-only proteins BNIP3 and BNIP3L in cancer. Cancer Metastasis Rev 26 (2007) 553-566
39. Tenedini E., Fagioli M.E., Vianelli N., et al. Gene expression profiling of normal and malignant CD34-derived megakaryocytic cells. Blood 104 (2004) 3126-3135
40. Murai M., Toyota M., Suzuki H., et al. Aberrant methylation and silencing of the BNIP3 gene in colorectal and gastric cancer. Clin Cancer Res 11 (2005) 1021-1027
41. Thiele J., Kvasnicka H.M., Zankovich R., et al. Clinical and morphological criteria for the diagnosis of prefibrotic idiopathic (primary) myelofibrosis. Ann Hematol 80 (2001) 160-165